These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 13130084
1. Satisfaction with onychomycosis treatment. Pulse versus continuous dosing. Warshaw EM, Bowman T, Bodman MA, Kim JJ, Silva S, Mathias SD. J Am Podiatr Med Assoc; 2003; 93(5):373-9. PubMed ID: 13130084 [Abstract] [Full Text] [Related]
2. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly. Gupta AK, Konnikov N, Lynde CW. J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118 [Abstract] [Full Text] [Related]
3. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. Gupta AK, Lynde CW, Konnikov N. J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119 [Abstract] [Full Text] [Related]
9. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. Gupta AK, Gover MD, Lynde CW. J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029 [Abstract] [Full Text] [Related]
10. Continuous terbinafine versus intermittent itraconazole for toenail onychomycosis. Warrick D, Church L. J Fam Pract; 1999 Jul; 48(7):492-3. PubMed ID: 10428238 [No Abstract] [Full Text] [Related]
11. Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature. Gupta AK, Gregurek-Novak T, Konnikov N, Lynde CW, Hofstader S, Summerbell RC. J Cutan Med Surg; 2001 Jul; 5(3):206-10. PubMed ID: 11685666 [Abstract] [Full Text] [Related]
17. Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. De Backer M, De Vroey C, Lesaffre E, Scheys I, De Keyser P. J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S57-63. PubMed ID: 9594939 [Abstract] [Full Text] [Related]
18. L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis. Sigurgeirsson B, Billstein S, Rantanen T, Ruzicka T, di Fonzo E, Vermeer BJ, Goodfield MJ, Evans EG. Br J Dermatol; 1999 Nov; 141 Suppl 56():5-14. PubMed ID: 10730908 [Abstract] [Full Text] [Related]